In another study involving patients with gastric cancer who underwent surgery, individuals with a higher proportion of CD103 in peripheral blood PD-1+CD8+ T cells at week 2 of immunotherapy exhibited significantly improved PFS (21). This evidence concerns the gene CD8A and gastric cancer.